Researchers from the University of North Carolina Health Care System have been exploring the role of a DNA repair enzyme in cells called Dicer. When they removed this enzyme from preclinical models of medulloblastoma, a brain cancer often found in children, they found increased levels of DNA damage that led to the cell’s death.

A major study has asked medical experts across the University of California, San Francisco, what they see as real developments in the coming year.

Scientists based at Diamond Light Source, the UK’s national synchrotron science facility in Oxfordshire, have used a technique known as x-ray fluorescence to track microscopic trace metals and correctly identify malignant brain tumour cells.

We were delighted to welcome our patron, Earl Spencer, to support us at a major fundraising event recently in the City of London. Here, he explains why he is committed to our cause.

The new blood test focuses on germ cell cancers that are rare but take root in cells that develop into sperm and eggs and may lead to malignant tumours in childhood.

New Zealand-based technology company, Genulin Interactive, have produced a cutting-edge visualisation of cancer immunotherapy.

In a report published yesterday in Cancer Cell journal, American researchers are focusing on gene mutations found in a third of brain gliomas.

On Wednesday 9th December the All Party Parliamentary Group (APPG) on Brain Tumours held a meeting in Westminster to discuss the new five year Independent Cancer Taskforce Strategy. The event was well attended and several MPs came along to listen to the experiences and concerns of our supporters.

Two new NHS proton beam centres have commenced construction with planners claiming they could treat 1,500 patients a year.

Deadly viruses are being combined with a cancer cell killing virus in trials aimed at destroying glioma brain tumours.

Our survey looking at quality of life issues in children, young people and families has been extended to ensure our findings have the biggest possible impact, we’d like closer to 500.

Tributes have been paid to The Brain Tumour Charity’s ‘sassy and brave’ Young Ambassador Tasha Floyd, who has died at the age of 24.

We were recently pleased to hear that the National Institute for Health and Care Excellence (NICE) will be developing a new guideline on primary brain tumours and cerebral metastases.

We’re aiming to tackle the issue of late diagnosis of brain tumours. For this to happen we’ve enlisted the support of researchers, GPs and our community, to drive awareness and effect change to diagnosis times. Spearheading this Christmas Campaign is Sophie O’Hagan.

Ewan MacKerracher, a ten year old boy from Coleraine, Northern Ireland, has been diagnosed twice in the past with brain tumours. He has been waiting almost two years for a routine scan that could show any recurrence of the disease.

China joins GBM AGILE, an Australasian adaptive clinical trial project tackling glioblastoma multiforme.

From Call of Duty to Candy Crush, digital games are played by millions around the world. But could they offer more than entertainment?

Scientists from the Translational Genomics Research Institute have identified the drug propentofylline (PPF) that limits the protein TROY in glioblastoma (GBM) cells and that also increases the effectiveness of chemotherapy drug temozolomide and radiation to treat GBM.

“Keep going because I promise you, you will succeed. Any dream you have, just smash it.”

In July 2015 Alice was discharged after nine years of treatment and monitoring for a brain tumour. Her mum Emma talks about what it means to get to the end of treatment.

A research team based in Catalonia, Spain, has pioneered a more accurate and less invasive liquid biopsy technique for brain tumours.

Australian researchers, coordinating with teams from Germany, have trialled genetically-modified algae loaded with chemotherapy drugs and found that they destroy 90% of cancer cells while leaving healthy ones intact.

We would like to invite you to our meeting of the All-Party Parliamentary Group (APPG) on Brain Tumours.

Brain tumour patients are more likely to be diagnosed via a hospital A&E department than those with any other type of tumour, new figures show.